Press Release: Family Caregivers Want Drug Approved for Hallucinations and Delusions

United States Department of Health and Human Services Food and Drug Administration

On June 17, 2022, Caregiver Action Network CEO John Schall testified. He spoke in front of the FDA Psychopharmacologic Drugs Advisory Committee. The testimony supported approving Acadia Pharmaceuticals Inc.’s supplemental new drug application for NUPLAZID. This drug treats the hallucinations and delusions of Alzheimer’s Disease psychosis. If approved, the drug would treat these behaviors associated with Alzheimer’s-related psychosis.

“Hallucinations and delusions can severely affect family caregivers,” said John Schall, CAN CEO. “Having a therapy to treat these symptoms will help caregivers keep their loved ones at home longer.”

Hallucinations and delusions are common in Alzheimer’s. These behaviors can get worse as the dementia progresses. Those suffering from them are at increased risk of hospitalization and may harm themselves or their families.

The challenge of dealing with hallucinations and delusions often leads family caregivers to place their loved ones in nursing homes.The FDA has approved medications that can help manage these symptoms, offering some relief to both patients and their caregivers.

Clinical trial results for NUPLAZID have been encouraging. Having a treatment for Alzheimer’s-related psychosis gives hope to family caregivers. They believe their loved one’s symptoms can be lessened.

More information and John Schall’s full statement can be found here.

About CAN

Caregiver Action Network (www.CaregiverAction.org) is the nation’s leading family caregiver organization working to improve the quality of life for more than 90 million Americans who care for loved ones with chronic conditions, disabilities, disease, or the frailties of old age. CAN serves a broad spectrum of family caregivers. This includes parents of children with significant health needs and families of wounded soldiers. They also support young couples facing MS diagnoses and adult children caring for parents with Alzheimer’s disease. CAN reaches caregivers through multiple platforms. CAN, the National Family Caregivers Association, is a 501(c)(3) non-profit organization. They provide education, peer support, and resources to family caregivers across the country free of charge.